Asia Pacific Injectable Drug Delivery Market worth $282.22 billion by 2031
The Report "Asia Pacific Injectable Drug Delivery Market by Product (Device, Autoinjectors, Formulation, Suspensions, Nanoparticles), Site of Administration (Dermal, Organ), Formulation Packaging (Ampoules, Vials), Usage Pattern (Curative, Immunization) – Forecast to 2031" is projected to grow from USD 176.96 billion in 2026 and to reach USD 282.22 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 9.8% during the forecast period.
Browse 320 market data Tables and 70 Figures spread through 380 Pages and in-depth TOC on "Asia Pacific Injectable Drug Delivery Market by Product (Device, Autoinjectors, Formulation, Suspensions, Nanoparticles), Site of Administration (Dermal, Organ), Formulation Packaging (Ampoules, Vials), Usage Pattern (Curative, Immunization) – Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/apac-injectable-drug-delivery-market-98962770.html
The Asia Pacific injectable drug delivery market is booming due to an aging demography, increasing cases of chronic diseases, and the prevalence of conditions requiring treatment via biologics and biosimilars on a large scale. With self-administration and patient-oriented therapy on the rise, the demand for advanced injectable delivery systems is increasing in China, Japan, South Korea, India, and Australia. Pharmaceutical and biotech companies are partnering with regional device manufacturers and CDMOs to optimize product performance, increase sterile manufacturing capacity, and comply with evolving regulatory standards. AI-enabled formulation design, smart injector technologies, automated fill-finish systems, and drug-device combination engineering are increasingly enhancing precision, consistency, and personalized dosing. The growing integration of digital health platforms, remote patient monitoring, and continuous manufacturing technologies is employed to increase efficacy, traceability, and general agility throughout the Asia Pacific injectable drug delivery ecosystem.
By formulation packaging, the ampoules segment accounted for the largest market share in 2025.
In the Asia Pacific injectable drug delivery market, the ampoules segment accounted for the largest market share in 2025. Ampoules are economical, easy to produce in mass quantities, and are widely used in hospitals, clinics, and emergency medical situations. Their excellent usability in vaccine, antibiotic, and volume-driven injectable drugs makes them a necessity in government health programs and everyday medical practices. They possess high sterility, tamper-resistance, and usability properties.
By end user, the long-term care settings segment is expected to grow at the highest CAGR during the forecast period.
Long-term care settings have recorded the highest CAGR due to the increasing elderly population in the Asia Pacific region, increasing demand for constant management of medication and chronic diseases. Long-term care centers opted for injection therapies in managing diabetes, cardiovascular diseases, and neurological diseases. The increased adoption of skilled nursing care, improvements in healthcare infrastructure, and rising consumption of pre-filled syringes & safety devices have driven rapid growth in this segment.
China accounted for the largest share of the market in 2025.
In 2025, China accounted for the largest share of the Asia Pacific injectable drug delivery market. China held the largest share due to the huge patient population, high chronic disease burdens, and a rapidly expanding market for biologics, biosimilars, and vaccines. The country has one of the most robust pharmaceutical manufacturing ecosystems, supported by substantial investments in injectable manufacturing and innovations. Favorable government healthcare reforms and an increase in the adoption of self-injections and home-based therapies continue to drive the market in China.
Key Market Players
The prominent players in the Asia Pacific injectable drug delivery market are BD (US), Terumo Corporation (Japan), Nipro (Japan), Hindustan Syringes & Medical Devices Ltd (India), B. Braun SE (Germany), Pfizer Inc. (US), Sanofi (France), F. Hoffmann-La Roche Ltd (Switzerland), Novo Nordisk A/S (Denmark), and Novartis AG (Switzerland), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the APAC Injectable Drug Delivery Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
